Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIBOFLAVIN 5^-PHOSPHATE: 244 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
244
Total FAERS Reports
9 (3.7%)
Deaths Reported
13
Hospitalizations
244
As Primary/Secondary Suspect
8
Life-Threatening
9
Disabilities

Active Ingredient: RIBOFLAVIN 5^-PHOSPHATE SODIUM ·

First Report: 20150101 · Latest Report: 20250915

What Are the Most Common RIBOFLAVIN 5^-PHOSPHATE Side Effects?

#1 Most Reported
Eye pain
53 reports (21.7%)
#2 Most Reported
Visual impairment
44 reports (18.0%)
#3 Most Reported
Corneal opacity
40 reports (16.4%)

All RIBOFLAVIN 5^-PHOSPHATE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Eye pain 53 21.7% 0 0
Visual impairment 44 18.0% 0 0
Corneal opacity 40 16.4% 0 0
No adverse event 38 15.6% 0 0
Therapy cessation 30 12.3% 0 0
Drug ineffective 26 10.7% 6 10
Corneal infiltrates 25 10.3% 0 0
Corneal scar 22 9.0% 0 0
Device issue 20 8.2% 0 0
Incorrect product administration duration 17 7.0% 2 2
Product use issue 16 6.6% 3 3
Vision blurred 16 6.6% 0 0
Ocular discomfort 15 6.2% 0 0
Ulcerative keratitis 14 5.7% 0 0
Corneal oedema 13 5.3% 0 0
Inappropriate schedule of product administration 13 5.3% 1 0
Keratitis 12 4.9% 0 0
Off label use 12 4.9% 8 10
Corneal epithelium defect 10 4.1% 0 0
Eye infection 10 4.1% 0 0

Who Reports RIBOFLAVIN 5^-PHOSPHATE Side Effects? Age & Gender Data

Gender: 39.6% female, 60.4% male. Average age: 34.8 years. Most reports from: US. View detailed demographics →

Is RIBOFLAVIN 5^-PHOSPHATE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2015 1 0 0
2016 1 0 0
2018 3 0 3
2019 2 0 0
2020 6 1 1
2021 34 0 0
2022 33 0 0
2023 34 0 0
2024 25 0 0
2025 16 0 0

View full timeline →

What Is RIBOFLAVIN 5^-PHOSPHATE Used For?

IndicationReports
Keratoconus 133
Product used for unknown indication 97
Corneal disorder 7

RIBOFLAVIN 5^-PHOSPHATE vs Alternatives: Which Is Safer?

RIBOFLAVIN 5^-PHOSPHATE vs RIFABUTIN RIBOFLAVIN 5^-PHOSPHATE vs RIFAMPICIN RIBOFLAVIN 5^-PHOSPHATE vs RIFAMPIN RIBOFLAVIN 5^-PHOSPHATE vs RIFAMYCIN RIBOFLAVIN 5^-PHOSPHATE vs RIFAPENTINE RIBOFLAVIN 5^-PHOSPHATE vs RIFAXIMIN RIBOFLAVIN 5^-PHOSPHATE vs RILMENIDINE RIBOFLAVIN 5^-PHOSPHATE vs RILONACEPT RIBOFLAVIN 5^-PHOSPHATE vs RILPIVIRINE RIBOFLAVIN 5^-PHOSPHATE vs RILUZOLE

Official FDA Label for RIBOFLAVIN 5^-PHOSPHATE

Official prescribing information from the FDA-approved drug label.